SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-058775
Filing Date
2023-11-03
Accepted
2023-11-03 15:47:12
Documents
81
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q eypt-20230930.htm   iXBRL 10-Q 2603729
2 EX-31.1 eypt-ex31_1.htm EX-31.1 14556
3 EX-31.2 eypt-ex31_2.htm EX-31.2 14721
4 EX-32.1 eypt-ex32_1.htm EX-32.1 6190
5 EX-32.2 eypt-ex32_2.htm EX-32.2 6401
  Complete submission text file 0000950170-23-058775.txt   9534302

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT eypt-20230930_pre.xml EX-101.PRE 376047
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT eypt-20230930_def.xml EX-101.DEF 235778
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT eypt-20230930.xsd EX-101.SCH 62784
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT eypt-20230930_lab.xml EX-101.LAB 488623
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT eypt-20230930_cal.xml EX-101.CAL 54157
75 EXTRACTED XBRL INSTANCE DOCUMENT eypt-20230930_htm.xml XML 1724471
Mailing Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472
Business Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472 617-926-5000
EyePoint Pharmaceuticals, Inc. (Filer) CIK: 0001314102 (see all company filings)

IRS No.: 262774444 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-51122 | Film No.: 231376145
SIC: 3826 Laboratory Analytical Instruments
Industrial Applications and Services